REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19. Piaserico S, Meneguzzo A, Messina F. J Infect 2020 Jun 28. pii: S0163-4453(20)30444.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Piaserico S, Meneguzzo A, Messina F. REPLY TO: Interleukin-17: a potential therapeutic target in COVID-19. J Infect 2020 Jun 28. pii: S0163-4453(20)30444.
PMID: 32610110